Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis

Abstract Background Coagulopathy has been reported in severely ill patients with coronavirus disease 2019 (COVID‐19). It is unclear whether outpatients with COVID‐19 who are treated with vitamin K antagonists (VKAs) have unstable anticoagulation. Objective To assess the stability of VKA therapy in p...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Eleonora Camilleri, Nienke van Rein, Felix J. M. van der Meer, Melchior C. Nierman, Willem M. Lijfering, Suzanne C. Cannegieter, The Dutch COVID & Thrombosis Coalition
Format: article
Langue:EN
Publié: Wiley 2021
Sujets:
Accès en ligne:https://doaj.org/article/3c754c07dfc24c7da8229b72505e669e
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!